1 – 15 of 15
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Workflows for the analysis of transcriptomic data at single-cell and spatial resolutions: T cells in lymphoma
(
- Master (Two yrs)
- 2023
-
Mark
Multi-omics integration of spatially resolved transcriptome and proteome data in mantle cell lymphoma
(
- Master (Two yrs)
-
Mark
Evaluating targeted combination therapies in EGFR wild-type non-small-cell lung cancer using mass spectrometry-based proteomics
(
- Master (Two yrs)
-
Mark
The Frequency and Biological Impact of CD25 Expression in Mantle Cell Lymphoma
(
- Master (Two yrs)
- 2022
-
Mark
PLK-1 inhibition has a functional impact on MYC and is a relevant target for high-risk mantle cell lymphoma patients
(
- Master (Two yrs)
- 2021
-
Mark
Drug-induced response and antibody-dependent cellular cytotoxicity in microfluidic cultures with dynamic flow
(
- Master (Two yrs)
-
Mark
Analysis of Myc Aberrations in Mantle Cell Lymphoma and Drug Target Identification
(
- Master (Two yrs)
-
Mark
DLBCL Patient stratification using serum protein profiling
(
- Master (Two yrs)
- 2020
-
Mark
Spatial Multiplex Analysis of Immune Cell Infiltration in Mantle Cell Lymphoma
(
- Master (Two yrs)
-
Mark
Microfluidic model for B-cell lymphoma
(
- Master (Two yrs)
-
Mark
Serum protein profiling of B-cell lymphoma cohorts using the IMMRay microarray technology
(
- Master (Two yrs)
- 2019
-
Mark
Molecular Investigations of Mantle Cell Lymphoma
(
- Master (Two yrs)
- 2017
-
Mark
Functional investigations of SPI-B and dCK in relation to cytarabine resistance in MCL
(
- Master (Two yrs)
-
Mark
Evaluation of CD44 and CD69 protein expression and pathway analysis of side population cells in mantle cell lymphoma
(
- Master (Two yrs)
- 2015
-
Mark
Development and Characterization of Resistance Models in Mantle Cell Lymphoma
(
- Master (Two yrs)